Literature DB >> 2392217

A comparison of sporadic and familial multiple sclerosis.

B G Weinshenker1, D Bulman, W Carriere, J Baskerville, G C Ebers.   

Abstract

We compared demographic and clinical features, including outcome defined by a failure time analysis of disability, in 143 patients with a family history of multiple sclerosis (familial MS) compared with 956 patients without such a history (sporadic MS). Patients with familial MS did not differ from those with sporadic MS even when patients with 1st-degree relatives or multiple relatives with MS were considered separately. An intraclass correlation analysis of 13 pairs of affected 1st-degree relatives, both members of which were followed in our clinic, failed to reveal heterogeneity among different families. We were unable to find any support for differences between familial and sporadic MS.

Entities:  

Mesh:

Year:  1990        PMID: 2392217     DOI: 10.1212/wnl.40.9.1354

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study.

Authors:  K Lauer; W Firnhaber
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

2.  Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.

Authors:  Małgorzata Siger-Zajdel; Krzysztof W Selmaj
Journal:  J Neurol       Date:  2005-03-18       Impact factor: 4.849

3.  Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.

Authors:  M Siger-Zajdel; K Selmaj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

4.  Susceptibility to multiple sclerosis is associated with the proximal immunoglobulin heavy chain variable region.

Authors:  M A Walter; W T Gibson; G C Ebers; D W Cox
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region.

Authors:  N W Wood; S J Sawcer; H F Kellar-Wood; P Holmans; D Clayton; N Robertson; D A Compston
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

6.  Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis.

Authors:  T Gabelic; D P Ramasamy; B Weinstock-Guttman; J Hagemeier; C Kennedy; R Melia; D Hojnacki; M Ramanathan; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

7.  Burden of genetic risk variants in multiple sclerosis families in the Netherlands.

Authors:  Julia Y Mescheriakova; Linda Broer; Simin Wahedi; André G Uitterlinden; Cornelia M van Duijn; Rogier Q Hintzen
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-05-06

8.  Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis.

Authors:  Monika Grudziecka Pyrek; Krzysztof Selmaj
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

9.  Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus.

Authors:  Patrick K A Kearns
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.